List view / Grid view
23 April 2014 | By Pfizer
Pfizer Inc. announced top-line results from two pivotal Phase 3 trials from the Oral treatment Psoriasis Trials (OPT) Program, OPT Pivotal #1 (A3921078) and OPT Pivotal #2 (A3921079)...
10 April 2014 | By Bristol-Myers Squibb Company
Bristol-Myers Squibb Company announced Phase III results from the global HALLMARK-Dual study investigating the all-oral, interferon- and ribavirin-free regimen of daclatasvir...
8 April 2014 | By OncoEthix
OncoEthix announced that the interim results from its ongoing Phase I clinical trial of OTX015, in patients with hematologic malignancies, were presented at the annual American Association of Cancer Research...
7 April 2014 | By The European Medicines Agency
In a meeting at the European Medicines Agency on 4 April 2014, the EMA’s Executive Director, Prof. Guido Rasi, and the National Manager of the Australian Therapeutic Goods AdministrationExternal link icon, Prof. John Skerritt, announced that the two regulators have agreed to share the full assessment reports...
7 April 2014 | By Roche
IQuum’s unique products will allow Roche to quickly enter the point of care segment of molecular diagnostics...
3 April 2014 | By Daiichi Sankyo
Daiichi Sankyo Co., Ltd. and University of California, San Francisco announced that they have established a drug discovery collaboration focused on developing novel therapeutics and molecular diagnostics for multiple neurodegenerative diseases...
2 April 2014 | By Lundbeck
H. Lundbeck A/S, together with a number of other companies, is now entering into a collaboration with the Lieber Institute, which has the world’s largest collection of human brains from patients with psychiatric disorders...
31 March 2014 | By AstraZeneca
AstraZeneca and the Medical Research Council announced that they have entered into a groundbreaking collaboration aimed at better understanding the mechanisms of human disease...
28 March 2014 | By Freddy White, Drug Target Review
Freddy White, Director, European Pharmaceutical Review & Drug Target Review speaks with Rohit Shroff, Application Specialist, Tecan at Pittcon 2014...
28 March 2014 | By Freddy White, Drug Target Review
Freddy White, Director, European Pharmaceutical Review & Drug Target Review Speaks With Richard Ladd, Senior Director pharmaceutical operations, Waters at Pittcon 2014...
27 March 2014 | By GlaxoSmithKline
Novel scientific collaboration to use genomics and big data to drive drug discovery...
26 March 2014 | By Pfizer
Pfizer Inc. announced the top-line results from a Phase 3B study evaluating the 24-month efficacy of GENOTROPIN®...
24 March 2014 | By AbbVie
AbbVie will present new data from its phase III hepatitis C development program at the 2014 International Liver Congress™...
20 March 2014 | By GlaxoSmithKline
GSK will continue the trial in order to assess the third co-primary endpoint, which is disease-free survival in a gene signature positive sub-population...
20 March 2014 | By AbbVie
AbbVie announced the initiation of a pivotal Phase 3 clinical trial that will evaluate the use of HUMIRA® (adalimumab)...
